Cargando…

SARS-CoV-2 in patients with Friedreich ataxia

Detalles Bibliográficos
Autores principales:	Shen, Megan M., Rodden, Layne N., McIntyre, Kellie, Arias, Adriana, Profeta, Victoria, Schadt, Kimberly, Lynch, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552162/ https://www.ncbi.nlm.nih.gov/pubmed/36219242 http://dx.doi.org/10.1007/s00415-022-11419-x

Ejemplares similares

Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia
por: Rodden, Layne N., et al.
Publicado: (2023)

FXN gene methylation determines carrier status in Friedreich ataxia
por: Lam, Christina, et al.
Publicado: (2023)

Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia
por: Rodden, Layne N., et al.
Publicado: (2022)

Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation
por: Rodden, Layne N., et al.
Publicado: (2021)

Friedreich Ataxia: Multidisciplinary Clinical Care
por: Lynch, David R, et al.
Publicado: (2021)

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
por: Mercado-Ayón, Elizabeth, et al.
Publicado: (2022)

DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
por: Rodden, Layne N., et al.
Publicado: (2022)

Friedreich Ataxia: Clinical Feature and Electrophysiological Symptoms
por: Oguri, Masayoshi
Publicado: (2017)

Friedreich Ataxia and nephrotic syndrome: a series of two patients
por: Shinnick, Julianna E., et al.
Publicado: (2016)

Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia
por: Rodden, Layne N, et al.
Publicado: (2021)

Identification of a novel missense mutation in Friedreich's ataxia –FXN(W) (168R)
por: Clark, Elisia, et al.
Publicado: (2019)

The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
por: Frempong, Bernice, et al.
Publicado: (2021)

Friedreich ataxia in COVID-19 time: current impact and future possibilities
por: Schirinzi, Tommaso, et al.
Publicado: (2021)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Short-read genome sequencing allows ‘en route’ diagnosis of patients with atypical Friedreich ataxia
por: Fleszar, Zofia, et al.
Publicado: (2023)

Progression of Friedreich ataxia: quantitative characterization over 5 years
por: Patel, Maya, et al.
Publicado: (2016)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Consensus clinical management guidelines for Friedreich ataxia
por: Corben, Louise A, et al.
Publicado: (2014)

A non-synonymous single nucleotide polymorphism in SIRT6 predicts neurological severity in Friedreich ataxia
por: Rodden, Layne N., et al.
Publicado: (2022)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Two Cases of Friedreich’s Ataxia
por: Stephenson, F. H.
Publicado: (1897)

Respiratory Function in Friedreich’s Ataxia
por: Vinante, Elena, et al.
Publicado: (2022)

Longitudinal analysis of contrast acuity in Friedreich ataxia
por: Hamedani, Ali G., et al.
Publicado: (2018)

Central Nervous System Therapeutic Targets in Friedreich Ataxia
por: Harding, Ian H., et al.
Publicado: (2020)

Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)
por: Lynch, David R., et al.
Publicado: (2020)

Psychometric properties of the Friedreich Ataxia Rating Scale
por: Rummey, Christian, et al.
Publicado: (2019)

Somatic instability of the expanded GAA repeats in Friedreich’s ataxia
por: Long, Ashlee, et al.
Publicado: (2017)

Test–retest reliability of the Friedreich’s ataxia rating scale
por: Rummey, Christian, et al.
Publicado: (2020)

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
por: Lynch, David R., et al.
Publicado: (2018)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
por: Cissé, Cheick A. K., et al.
Publicado: (2021)

Frataxin levels in peripheral tissue in Friedreich ataxia
por: Lazaropoulos, Michael, et al.
Publicado: (2015)

Anaesthesia for a patient with Friedreich's ataxia
por: Ganesan, Ilango
Publicado: (2011)

Hepatic mitochondrial dysfunction in Friedreich Ataxia
por: Stüwe, Sven H, et al.
Publicado: (2011)

Epigenetic-based therapies for Friedreich ataxia
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ejgp4o6n23gdosaob5bn581979